These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 7083158

  • 1. Molecular pharmacology of the anthracycline drug 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (Cl 216,942).
    Bowden GT, Garcia D, Peng YM, Alberts DS.
    Cancer Res; 1982 Jul; 42(7):2660-5. PubMed ID: 7083158
    [Abstract] [Full Text] [Related]

  • 2. Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantrene.
    Bowden GT, Roberts R, Alberts DS, Peng YM, Garcia D.
    Cancer Res; 1985 Oct; 45(10):4915-20. PubMed ID: 4027978
    [Abstract] [Full Text] [Related]

  • 3. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV, Wallace RE, Murdock KC, Angier RB, Durr FE, Forbes M.
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [Abstract] [Full Text] [Related]

  • 4. Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors.
    Pierson V, Pierre A, Pommier Y, Gros P.
    Cancer Res; 1988 Mar 15; 48(6):1404-9. PubMed ID: 2830964
    [Abstract] [Full Text] [Related]

  • 5. Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
    Alberts DS, Mackel C, Pocelinko R, Salmon SE.
    Cancer Res; 1982 Mar 15; 42(3):1170-5. PubMed ID: 7037174
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Zwelling LA, Kerrigan D, Michaels S.
    Cancer Res; 1982 Jul 15; 42(7):2687-91. PubMed ID: 6896293
    [Abstract] [Full Text] [Related]

  • 7. Interactions of mitomycin C with mammalian DNA detected by alkaline elution.
    Dorr RT, Bowden GT, Alberts DS, Liddil JD.
    Cancer Res; 1985 Aug 15; 45(8):3510-6. PubMed ID: 3926301
    [Abstract] [Full Text] [Related]

  • 8. In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells.
    DeNeve W, Valeriote F, Edelstein M, Everett C, Bischoff M.
    Cancer Res; 1989 Jul 01; 49(13):3452-6. PubMed ID: 2731167
    [Abstract] [Full Text] [Related]

  • 9. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR, Chen SF, Behrens CH, Papp LM, Stafford MM, Sun JH, Behrens DL, Fredericks JR, Polkus ST, Sipple P.
    Cancer Res; 1994 Apr 15; 54(8):2199-206. PubMed ID: 8174127
    [Abstract] [Full Text] [Related]

  • 10. Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells.
    Traganos F, Evenson DP, Staiano-Coico L, Darzynkiewicz Z, Melamed MR.
    Cancer Res; 1980 Mar 15; 40(3):671-81. PubMed ID: 6162553
    [Abstract] [Full Text] [Related]

  • 11. Effects of dimethyl sulfoxide and thiourea upon intercalator-induced DNA single-strand breaks in mouse leukemia (L1210) cells.
    Pommier Y, Zwelling LA, Mattern MR, Erickson LC, Kerrigan D, Schwartz R, Kohn KW.
    Cancer Res; 1983 Dec 15; 43(12 Pt 1):5718-24. PubMed ID: 6416668
    [Abstract] [Full Text] [Related]

  • 12. Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II.
    Markovits J, Pommier Y, Mattern MR, Esnault C, Roques BP, Le Pecq JB, Kohn KW.
    Cancer Res; 1986 Nov 15; 46(11):5821-6. PubMed ID: 3019538
    [Abstract] [Full Text] [Related]

  • 13. 1,4-disubstituted anthracene antitumor agents.
    Iyengar BS, Dorr RT, Alberts DS, Sólyom AM, Krutzsch M, Remers WA.
    J Med Chem; 1997 Nov 07; 40(23):3734-8. PubMed ID: 9371238
    [Abstract] [Full Text] [Related]

  • 14. Reduced bisantrene-induced cytotoxicity and protein-associated DNA strand breaks under hypoxic condition.
    Ludwig CU, Bowden GT, Roberts RA, Alberts DS.
    Cancer Treat Rep; 1984 Feb 07; 68(2):367-72. PubMed ID: 6697326
    [Abstract] [Full Text] [Related]

  • 15. Effects of the antitumor agent 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one on the DNA of mouse L1210 cells.
    Gibson NW, Erickson LC, Hickman JA.
    Cancer Res; 1984 May 07; 44(5):1767-71. PubMed ID: 6713380
    [Abstract] [Full Text] [Related]

  • 16. Production by lithocholic acid of DNA strand breaks in L1210 cells.
    Kulkarni MS, Heidepriem PM, Yielding KL.
    Cancer Res; 1980 Aug 07; 40(8 Pt 1):2666-9. PubMed ID: 7388816
    [Abstract] [Full Text] [Related]

  • 17. Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (CL216,942).
    Von Hoff DD, Myers JW, Kuhn J, Sandbach JF, Pocelinko R, Clark G, Coltman CA.
    Cancer Res; 1981 Aug 07; 41(8):3118-21. PubMed ID: 6265075
    [Abstract] [Full Text] [Related]

  • 18. Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.
    Capranico G, Soranzo C, Zunino F.
    Cancer Res; 1986 Nov 07; 46(11):5499-503. PubMed ID: 3463414
    [Abstract] [Full Text] [Related]

  • 19. DNA damage and repair in L1210 cells exposed to 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Hilton J, Bowie DL, Gutin PH, Zito DM, Walker MD.
    Cancer Res; 1977 Jul 07; 37(7 Pt 1):2262-6. PubMed ID: 861950
    [Abstract] [Full Text] [Related]

  • 20. DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity.
    Wozniak AJ, Ross WE.
    Cancer Res; 1983 Jan 07; 43(1):120-4. PubMed ID: 6847761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.